Natera and CytoDyn have formed a strategic collaboration to evaluate ctDNA dynamics and molecular responses in metastatic colorectal cancer. This partnership will leverage Natera's personalized assays and extensive oncology database to support CytoDyn's clinical trials and enhance understanding of treatment effects.
Company Information
Company
Natera
Location
13011 Mccallen Pass
Austin, Texas, United States
About
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.